AI
SUPN icon

AdvisorShares Investments’s Supernus Pharmaceuticals SUPN Stock Holding History

AdvisorShares Investments’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$902K Sell
17,453
-10,941
-39% -$557K 0.16% 89
2025
Q4 		$1.41M Buy
28,394
+12,869
+83% +$626K 0.24% 57
2025
Q3 		$742K Buy
+15,525
New +$625K 0.12% 91

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AdvisorShares Investments's SUPN Position: Q1 2026 in Review

AdvisorShares Investments reduced its Supernus Pharmaceuticals (SUPN) stake by 39% in Q1 2026, selling an estimated $557K and leaving 17,453 shares worth $902K. The position accounts for 0.16% of the portfolio, ranked #89.

AdvisorShares Investments first reported a position in SUPN in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.41M in Q4 2025. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • AdvisorShares Investments held 17,453 shares of Supernus Pharmaceuticals worth $902K as of Q1 2026.
  • AdvisorShares Investments sold 10,941 Supernus Pharmaceuticals shares in Q1 2026, an estimated $557K.
  • Supernus Pharmaceuticals made up 0.16% of AdvisorShares Investments's portfolio in Q1 2026, its #89 holding.
  • AdvisorShares Investments first reported a position in Supernus Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • AdvisorShares Investments's Supernus Pharmaceuticals position peaked at $1.41M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on AdvisorShares Investments's 13F filing for Q1 2026, filed 28 Apr 2026.